U.S. Capital Wealth Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.31M | Buy |
47,988
+39,215
| +447% | +$2.71M | 0.1% | 212 |
|
|
2025
Q1 | $609K | Buy |
8,773
+1,843
| +27% | +$128K | 0.02% | 540 |
|
|
2024
Q4 | $596K | Sell |
6,930
-75
| -1% | -$6.45K | 0.02% | 525 |
|
|
2024
Q3 | $834K | Sell |
7,005
-11,217
| -62% | -$1.34M | 0.03% | 378 |
|
|
2024
Q2 | $2.6M | Sell |
18,222
-3,071
| -14% | -$438K | 0.1% | 194 |
|
|
2024
Q1 | $2.73M | Buy |
21,293
+5,872
| +38% | +$754K | 0.11% | 185 |
|
|
2023
Q4 | $1.6M | Buy |
15,421
+90
| +0.6% | +$9.31K | 0.06% | 266 |
|
|
2023
Q3 | $1.39M | Sell |
15,331
-1,423
| -8% | -$129K | 0.06% | 259 |
|
|
2023
Q2 | $1.36M | Sell |
16,754
-578
| -3% | -$46.8K | 0.06% | 270 |
|
|
2023
Q1 | $1.38M | Sell |
17,332
-402
| -2% | -$32K | 0.06% | 259 |
|
|
2022
Q4 | $1.2M | Buy |
17,734
+1,498
| +9% | +$101K | 0.06% | 297 |
|
|
2022
Q3 | $809K | Buy |
16,236
+146
| +0.9% | +$7.28K | 0.04% | 359 |
|
|
2022
Q2 | $896K | Buy |
16,090
+710
| +5% | +$39.5K | 0.04% | 368 |
|
|
2022
Q1 | $854K | Sell |
15,380
-144
| -0.9% | -$8K | 0.03% | 421 |
|
|
2021
Q4 | $869K | Buy |
15,524
+898
| +6% | +$50.3K | 0.03% | 422 |
|
|
2021
Q3 | $702K | Buy |
+14,626
| New | +$702K | 0.03% | 449 |
|